Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Update Il y a 4 ans
Reference: NCT00582738

Woman and Man

  • | Country :
  • Argentina
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study will assess the efficacy of everolimus as an inhibitor of fibrosis progression in liver transplant patients who have a recurrence of hepatitis C viral infection in the transplant


Inclusion criteria

  • Recurrent Hepatitis C

Links